Comparing treatment and outcomes in advanced esophageal, gastroesophageal junction, and gastric adenocarcinomas: a population-based study

Comparing treatment and outcomes in advanced esophageal, gastroesophageal junction, and gastric adenocarcinomas: a population-based study

Background: Treatment of advanced or metastatic esophageal adenocarcinoma (EAC) follows the guidelines for gastroesophageal junction adenocarcinoma (GEJC) and gastric adenocarcinoma (GAC), but patients with EAC are often excluded from clinical studies of GEJC/GAC. Objectives: Here we describe treatm...

Full description

Bibliographic Details
Main Authors:	Marieke Pape, Pauline A. J. Vissers, Willemieke P. M. Dijksterhuis, David Bertwistle, Laura McDonald, Bianca Mostert, Sarah Derks, Irma M. Oving, Rob H. A. Verhoeven, Hanneke W. M. van Laarhoven
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-03-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/17588359231162576

Similar Items

Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: a nationwide cohort study in the NetherlandsResearch in context
by: Hanneke van Laarhoven, et al.
Published: (2025-02-01)

A population-based study in synchronous metachronous metastatic esophagogastric adenocarcinoma
by: Marieke Pape, et al.
Published: (2022-03-01)

Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer
by: Sarah Derks, et al.
Published: (2022-12-01)

Emerging targets in gastroesophageal adenocarcinoma: what the future looks like
by: Angelica Petrillo, et al.
Published: (2023-05-01)

Understanding the Challenges Faced by Esophageal and Gastroesophageal Junction Cancer Survivors
by: Erin McGillivray MD, et al.
Published: (2023-06-01)

AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gastroesophageal junction adenocarcinomas
by: Pradipta Ghosh, et al.
Published: (2022-09-01)

Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma.
by: Sijana H Dzinic, et al.
Published: (2019-01-01)

Role of palliative chemotherapy and targeted therapy in advanced esophageal and gastroesophageal junction cancers
by: Vijai Simha, et al.
Published: (2019-01-01)

Isolated Splenic Metastases of Her2+++ Gastroesophageal Junction Adenocarcinoma
by: Julie Sigrand, et al.
Published: (2016-03-01)

Surgical Treatment of Patients with Adenocarcinoma of the Distal Esophageal Portion and Gastroesophageal Junction Performed After Neoadjuvant Chemotherapy and Combined Chemoradiation
by: Yankov G., et al.
Published: (2022-04-01)

Atypical presentation in adolescence of a gastroesophageal junction adenocarcinoma
by: G. Amaya Villagrán, et al.
Published: (2023-07-01)

Gastroesophageal junction adenocarcinoma. A case report
by: Marcos Félix Osorio Pagola, et al.
Published: (2010-12-01)

Pembrolizumab for first-line treatment of advanced unresectable or metastatic esophageal or gastroesophageal junction cancer
by: Toshiharu Hirose, et al.
Published: (2023-01-01)

Inguinal mass: An unusual presentation of gastroesophageal junction adenocarcinoma
by: Gourav Kaushal, et al.
Published: (2017-01-01)

Adenocarcinoma of the Gastroesophageal Junction Masquerading as Mallory-Weiss Syndrome
by: Takeshi Okamoto, et al.
Published: (2022-01-01)

Dedifferentiated Liposarcoma of the Gastroesophageal Junction
by: Gökçe AŞKAN, et al.
Published: (2018-01-01)

Eligibility and workload implications of adjuvant immunotherapy in patients with resected esophageal and gastroesophageal junction (ESO/GEJ) cancer
by: T.H. Lee, et al.
Published: (2025-03-01)

Meningeal Carcinomatosis: A Metastasis from Gastroesophageal Junction Adenocarcinoma
by: Tanya Dam, et al.
Published: (2013-01-01)

Neoadjuvant chemoimmunotherapy in locally advanced gastric or gastroesophageal junction adenocarcinoma
by: Xiao Liu, et al.
Published: (2024-04-01)

Incidence of microscopically positive proximal margins in adenocarcinoma of the gastroesophageal junction.
by: Fei Gao, et al.
Published: (2014-01-01)

Expression and Prognostic Value of RAD51 in Adenocarcinoma at the Gastroesophageal Junction
by: Darebai Redati, et al.
Published: (2022-10-01)

Feasibility trial of STRONG: A digital intervention to improve nutritional management for individuals with esophageal and gastroesophageal junction cancer
by: Yu Chen Lin, et al.
Published: (2025-02-01)

The epidemiological trends and predictions of esophageal squamous cell carcinoma and gastroesophageal junction carcinoma: an Australian population-based study
by: Shalika Bohingamu Mudiyanselage, et al.
Published: (2024-12-01)

A Prospective Study of Eosinophilic Esophagitis and the Expression of Tight Junction Proteins in Patients with Gastroesophageal Reflux Disease Symptoms
by: Kenichiro Okimoto, et al.
Published: (2018-01-01)

The impact of hiatal hernia on survival outcomes in patients with gastroesophageal junction adenocarcinoma
by: Yuya Tanaka, et al.
Published: (2022-05-01)

A patient with gastroesophageal junction carcinoma and cough
by: Priyanka S Makkar, et al.
Published: (2021-01-01)

1361 Neoadjuvant CD40 agonism remodels the tumor immune microenvironment in locally advanced esophageal/gastroesophageal junction cancer
by: Li Zhang, et al.
Published: (2023-11-01)

Efficacy and safety of neoadjuvant immunotherapy in resectable esophageal or gastroesophageal junction carcinoma: A pooled analysis of prospective clinical trials
by: Jie Zhu, et al.
Published: (2022-12-01)

Gastric adenocarcinoma with enteroblastic differentiation over the gastroesophageal junction: A case report
by: Yan-Li Zou, et al.
Published: (2025-03-01)

Canadian Consensus Recommendations for Predictive Biomarker Testing in Gastric and Gastroesophageal Junction Adenocarcinoma
by: Christine Brezden-Masley, et al.
Published: (2024-12-01)

Definitive Chemoradiation for Gastroesophageal junction (GEJ) Adenocarcinomas: A Single-Institution Experience
by: Farshid Farhan, et al.
Published: (2024-04-01)

Identification and analysis of key genes in association with development and progression of adenocarcinoma at the gastroesophageal junction
by: WANG Yu-qian, CHEN Ya-mei, YANG Jie, LIN Yuan, LUO Ying-ying, ZHANG Shao-sen, WU Chen
Published: (2021-06-01)

Nivolumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: a cost-effectiveness analysis
by: Peng-Fei Zhang, et al.
Published: (2023-09-01)

First-line nivolumab plus chemotherapy chemotherapy alone for advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma: a cost-effectiveness analysis
by: Xueqiong Cao, et al.
Published: (2023-05-01)

Esophageal motor abnormalities in gastroesophageal reflux disorders
by: Wei-Yi Lei, et al.
Published: (2024-01-01)

A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination defective metastatic esophageal/gastroesophageal junction/proximal gastric adenocarcinoma
by: Ahmed Bilal Khalid, et al.
Published: (2024-11-01)

Prevalence of human papillomavirus and Helicobacter pylori in esophageal and gastroesophageal junction cancer biopsies from a case–control study in Ethiopia
by: Maria E. Leon, et al.
Published: (2019-08-01)

Case of Gastroesophageal Reflux Disease Resulted in Secondary Esophageal Spasm
by: A. Yu. Ishchenko, et al.
Published: (2023-06-01)

Gastroesophageal junction cancer - current topic and treatment dilemmas
by: Milošević Nikola, et al.
Published: (2024-01-01)

Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer
by: Lisa Paschold, et al.
Published: (2022-02-01)